Multicentre Trial Evaluates AI-Assisted MRI Interpretation for Prostate Cancer Detection — Implications for Radiology Workflow
247 Health News Editorial
·22 May 2026
·4 min read
·clinical-trialsNew US trial evaluates AI-assisted MRI interpretation for prostate cancer detection, comparing radiologist performance with and without artificial intelligence support. Results could transform prostate imaging workflows globally.
Originally reported by ClinicalTrials.gov
References
- 1.Australian Institute of Health and Welfare. (2023). Cancer in Australia 2023 (CAN 144). AIHW. https://www.aihw.gov.au/reports/cancer/cancer-in-australia-2023
- 2.Case Comprehensive Cancer Center. (2024). Investigation of Impact of AI on Prostate Cancer Workflow. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07084779
- 3.Cuocolo, R., Cipullo, M. B., Stanzione, A., Romeo, V., Green, R., Cantoni, V., Ponsiglione, A., Ugga, L., & Imbriaco, M. (2020). Machine learning applications in prostate cancer magnetic resonance imaging. European Radiology Experimental, 4(1), 35. https://doi.org/10.1186/s41747-019-0109-2
- 4.Giganti, F., Allen, C., Emberton, M., Moore, C. M., & Kasivisvanathan, V. (2020). Prostate imaging quality (PI-QUAL): a new quality control scoring system for multiparametric magnetic resonance imaging of the prostate. European Urology Oncology, 3(5), 615-619. https://doi.org/10.1016/j.euo.2019.03.001
- 5.Greer, M. D., Brown, A. M., Shih, J. H., Summers, R. M., Marko, J., Law, Y. M., Sankineni, S., George, A. K., Merino, M. J., Pinto, P. A., Choyke, P. L., & Turkbey, B. (2019). Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study. Journal of Magnetic Resonance Imaging, 49(2), 482-495. https://doi.org/10.1002/jmri.26645
- 6.Kasivisvanathan, V., Rannikko, A. S., Borghi, M., Panebianco, V., Mynderse, L. A., Vaarala, M. H., Briganti, A., Budäus, L., Hellawell, G., Hindley, R. G., Roobol, M. J., Eggener, S., Ghei, M., Villers, A., Bladou, F., Villeirs, G. M., Virdi, J., Boxler, S., Robert, G., ... Moore, C. M. (2018). MRI-targeted or standard biopsy for prostate-cancer diagnosis. New England Journal of Medicine, 378(19), 1767-1777. https://doi.org/10.1056/NEJMoa1801993
- 7.Mottet, N., van den Bergh, R. C. N., Briers, E., Van den Broeck, T., Cumberbatch, M. G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., Grivas, N., Grummet, J., Henry, A. M., van der Kwast, T. H., Lam, T. B., Lardas, M., Liew, M., Mason, M. D., Moris, L., ... Cornford, P. (2021). EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. European Urology, 79(2), 243-262. https://doi.org/10.1016/j.eururo.2020.09.042
2
247 Health News Editorial
247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.
Related Articles
clinical-trials
Digital Health Platform vs Case Manager Support in Hypertension Management: Taiwan's 1,726-Participant Trial Signals a Shift in Blood Pressure Care Delivery
3 Aug 2026
clinical-trials
Phase II Trial: AI-Powered Wysa Chatbot vs Unmet Need — Digital Eating Disorder Prevention in At-Risk Adolescents
3 Aug 2026
clinical-trials
Pilot Trial Targets the Inpatient-to-Outpatient Gap: Digital Smoking Cessation Intervention for Persons With Serious Mental Illness — Key Findings for Clinicians
3 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service